EDGAR·FLOW

Medline Inc. — Form 8-K

Filed November 18, 2026 · analyzed by the 8-K Agent
8-K — Neutral significance 28/100
What the filing says
Medline Inc. and Medline Holdings, LP agreed to repurchase $200 million in Class A common stock and limited partnership units directly from selling stockholders (Blackstone, Carlyle, Hellman Friedman, GIC Private Limited, and Abu Dhabi Investment Authority affiliates) at $35.50 per share—the same price as the concurrent 60 million share secondary offering priced November 17, 2026. The repurchase will close concurrently with the secondary offering, with sellers also transferring equivalent Class B shares to be cancelled. No new proceeds to Medline.
Why this rating

$200M repurchase is ~1.5% of $13B market cap. Standard capital allocation; offsets dilution from 60M secondary offering but no new cash benefit.

View original filing on SEC.gov ↗ MDLN · stock on Yahoo Finance ↗

See more from November 18, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.